Victory Capital Management Inc. Has $1.38 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Victory Capital Management Inc. trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 48.6% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 18,942 shares of the company’s stock after selling 17,898 shares during the quarter. Victory Capital Management Inc.’s holdings in Henry Schein were worth $1,381,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. American Century Companies Inc. grew its holdings in shares of Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after buying an additional 162,477 shares during the last quarter. Swedbank AB purchased a new position in Henry Schein during the 1st quarter worth $215,998,000. Nuance Investments LLC lifted its position in shares of Henry Schein by 6.2% during the second quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after purchasing an additional 108,143 shares in the last quarter. Burgundy Asset Management Ltd. grew its position in Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock worth $105,148,000 after purchasing an additional 16,476 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Henry Schein by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock valued at $104,764,000 after buying an additional 149,517 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on HSIC shares. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. JPMorgan Chase & Co. cut their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Finally, Robert W. Baird cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $78.89.

Insider Transactions at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Trading Up 2.3 %

Shares of HSIC opened at $76.84 on Tuesday. The stock has a market capitalization of $9.58 billion, a P/E ratio of 31.62, a PEG ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a fifty day simple moving average of $70.89 and a two-hundred day simple moving average of $69.73.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period in the prior year, the business posted $1.32 earnings per share. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. On average, research analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.